Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. Dassault to enhance clinical tech with $5.8bn Medidata acquisition
  2. Medidata: moving towards virtualised, patient-centric trials
  3. Pembrolizumab trumps chemotherapy in recurrent head and neck cancer
  4. Lynparza reduces PFS in germline BRCA-mutated pancreatic cancer
  5. Novartis’ IND/MF drug achieves endpoints in Phase III study

Latest Content

Takeda’s Ninlaro fails in Phase III trial for treatment of amyloidosis

Despite being a successful treatment for multiple myeloma since it was first approved, the Phase III trial result is a setback for Takeda's Ninlaro. Takeda is investigating the combination of Ninlara and chemotherapy for AL amyloidosis and this combination is currently in Phase II trials with results expected next year.

Medidata: moving towards virtualised, patient-centric trials

At its London NEXT conference, Medidata representatives discussed how technology will transform the future of clinical trials. One of the ways that the company sees clinical development advancing in the coming years is though a virtual and patient-centric approach, and therefore Medidata is seeking to get ahead of the curve by starting to implement these theories into its strategies and platform.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:


Go Top